Botulinum toxin in trigeminal neuralgia

Area of Science:

• Neurology
• Pain Management
• Pharmacology

Background:

• Trigeminal neuralgia is a severe facial pain syndrome impacting quality of life.
• Pharmacotherapy is the primary treatment, but drug resistance necessitates alternative strategies.
• Interventional treatments are explored for refractory cases, with botulinum toxin emerging as a promising option.

Purpose of the Study:

• To review the literature on botulinum toxin for drug-refractory trigeminal neuralgia.
• To assess the safety and efficacy of botulinum toxin in treating trigeminal neuralgia.

Main Methods:

• Literature review of clinical cases, case series, open-label studies, and randomized clinical trials.
• Focused on studies investigating botulinum toxin for trigeminal neuralgia unresponsive to conventional medication.

Main Results:

• Botulinum toxin administration demonstrated safety and effectiveness in patients with drug-refractory idiopathic trigeminal neuralgia.
• The reviewed literature supports botulinum toxin as a viable therapeutic strategy.

Conclusions:

• Botulinum toxin is a safe and effective option for drug-resistant trigeminal neuralgia.
• Unanswered questions remain regarding the precise therapeutic role of botulinum toxin in trigeminal neuralgia treatment.